Cyclin D1 antibody (Ser90) (Biotin)
Quick Overview for Cyclin D1 antibody (Ser90) (Biotin) (ABIN1955169)
Target
See all Cyclin D1 (CCND1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Ser90
-
Specificity
- Human CCND1 / Cyclin D1
-
Purification
- Immunoaffinity purified
-
Immunogen
-
KLH-conjugated synthetic non-phosphopeptide around Ser90 of human Cyclin D1.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA, IHC, WB
Usage: The applications listed above are for the unconjugated form of this antibody. The conjugated antibody has not been tested. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Expiry Date
- 6 months
-
-
- Cyclin D1 (CCND1)
-
Alternative Name
- CCND1 / Cyclin D1
-
Background
-
Name/Gene ID: CCND1
Synonyms: CCND1, B-cell lymphoma 1 protein, BCL-1 oncogene, B-cell CLL/lymphoma 1, BCL-1, Cyclin D1, G1/S-specific cyclin-D1, U21B31, PRAD1, BCL1, D11S287E, PRAD1 oncogene -
Gene ID
- 595
-
Pathways
- PI3K-Akt Signaling, Cell Division Cycle, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
Target
-